Comparison of a Generic to Disease-Targeted Health-Related Quality-of-Life Measures for Multiple Sclerosis

Published In: Journal of Clinical Epidemiology, v. 50, no. 5, May 1997, p. 557-569

Posted on on January 01, 1997

by Barbara Vickrey, Ron D. Hays, Barbara Genovese, Lawrence W. Myers, George W. Ellison

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

Deals with the comparison of a generic measure to a disease-targeted health-related quality-of-life measure for multiple sclerosis. The article is based on data obtained from 171 adults with multiple sclerosis, and compares a generic measure and a disease-targeted instrument. The major conclusion of this study is that results indicate that the disease-targeted scales provide unique information not captured by the generic measures. If a generic measure of health-related quality of life is desirable for a given study of multiple sclerosis, additional information will be gained by supplementing that measure with selected scales. The results of this study are consistent with studies from other diseases suggesting that when measuring health-related quality of life, one should supplement generic measures with disease-specific measures to get a full assessment of the impact of a therapy on health-related quality of life.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.